University of California San Francisco

At USCF there are two research groups exploring psychedelics. At the Neuroscape center, researchers are engaged in multiple areas of neuroscience research. The Neuroscape Psychedelic Division was launched in March 2021 and is led by Dr Robin Carhart-Harris. The team aim to investigate the positive influence of psychedelics on neural network dynamics and long-term neuroplasticity in healthy human research participants using various neuroimaging techniques. The Clinical Division at the center are engaged in clinical trials using psychedelic’s and the center is currently a site for an additional Phase-III clinical trial investigating the therapeutic effects of MDMA-assisted therapy for PTSD.

The Translational Psychedelic Research (TrPR) Program is another research initiative at UCSF seeking to enhance our understanding of how psychedelics impact the brain and other organ systems. The team are currently recruiting for a pilot study exploring the effects if psilocybin on anxiety and depression in people with Parkinson’s disease. Additionally, the team at the TrPR are conducting a trail in collaboration with the Usona Institute investing a single dose of psilocybin in people with major depressive disorder. The TrPR have a number of other studies planned with psilocybin.

Company Information

University of California San Francisco Website

March, 2021


Research Institute

Topics of Interest

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


505 Parnassus Ave, San Francisco, CA 94143, United States